Related references
Note: Only part of the references are listed.Expansion of the Gene Ontology knowledgebase and resources
S. Carbon et al.
NUCLEIC ACIDS RESEARCH (2017)
Deubiquitinating Enzyme USP20 Regulates Extracellular Signal- Regulated Kinase 3 Stability and Biological Activity
Simon Mathien et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells
Lobna Elkhadragy et al.
MOLECULAR ONCOLOGY (2017)
MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia
Juanjuan Tan et al.
SCIENTIFIC REPORTS (2017)
ERK3 regulates TDP2-mediated DNA damage response and chemoresistance in lung cancer cells
Ka Bian et al.
ONCOTARGET (2016)
Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis
Carolina Zandueta et al.
JOURNAL OF PATHOLOGY (2016)
OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs
Jordan Anaya
PEERJ COMPUTER SCIENCE (2016)
A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration
Rania Al-Mahdi et al.
CELL ADHESION & MIGRATION (2015)
Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
Jacob R. Haling et al.
CANCER CELL (2014)
ERK3 Promotes Endothelial Cell Functions by Upregulating SRC-3/SP1-Mediated VEGFR2 Expression
Wei Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion
Weiwen Long et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
NADPH Oxidase 1 Overexpression Enhances Invasion via Matrix Metalloproteinase-2 and Epithelial-Mesenchymal Transition in Melanoma Cells
Feng Liu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
Marie Cargnello et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2011)
Genotype-Dependent Sensitivity of Uveal Melanoma Cell Lines to Inhibition of B-Raf, MEK, and Akt Kinases: Rationale for Personalized Therapy
Nicholas Mitsiades et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Sonja J. Heidorn et al.
CELL (2010)
Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma
Sonja Mertsch et al.
BMC CANCER (2009)
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice
V. K. Goel et al.
ONCOGENE (2009)
BRAF kinase in melanoma development and progression
Amena M. DeLuca et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases
Lei Xu et al.
MOLECULAR CANCER RESEARCH (2008)
Osteopontin: role in cell signaling and cancer progression
H Rangaswami et al.
TRENDS IN CELL BIOLOGY (2006)
Novel genes associated with malignant melanoma but not benign melanocytic lesions
D Talantov et al.
CLINICAL CANCER RESEARCH (2005)
Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer
Bin Liang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
N-terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome
P Coulombe et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Statistics review 12: Survival analysis
V Bewick et al.
CRITICAL CARE (2004)
Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation
P Coulombe et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)